一心堂(002727.SZ):投資設立控股子公司一心堂醫養並取得營業執照
格隆匯 6 月 29日丨一心堂(002727.SZ)公佈,公司主營業務為藥品零售連鎖,全面轉型大健康藥店以來,公司始終以健康類產品經營為核心,致力於為廣大民眾提供專業、全面的健康解決方案。為協同一心堂大健康產業戰略的發展需求,以零售藥店為支點,在顧客健康管理為核心的大健康產業,公司全資子公司一心堂健康管理有限公司(以下簡稱“一心堂健康”)擬與自然人張玉霞共同出資設立一心堂醫養服務股份公司(暫定名,具體名稱以主管機關核定為準)(以下簡稱“一心堂醫養”)。一心堂醫養註冊資本為人民幣5000萬元,其中一心堂健康認繳出資人民幣4500萬元,佔比一心堂醫養註冊資本90%;張玉霞認繳出資人民幣500萬元,佔比一心堂醫養註冊資本10%。
控股子公司一心堂醫養辦理完畢工商註冊登記手續,並取得由昆明市市場監督管理局頒發的《營業執照》。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.